InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Denis Drygin, Chief Scientific Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 2 open-market SEC Form 4 transactions: 2 purchases worth $23K and 0 sales worth $0, reported from Feb 4, 22 to Mar 1, 22. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 1, 22 | RGLSRegulus Therapeutics Inc. | BUY | 76.7K | $0.23 | $18K |
| Feb 4, 22 | RGLSRegulus Therapeutics Inc. | BUY | 23.3K | $0.23 | $5K |